Yewande Fashakin

Yewande Fashakin has had a progressive career in the field of accounting, starting as an Operations Accountant at McKesson in 2002. Yewande then worked as a Financial Analyst at Codman, a Johnson and Johnson Company, before joining Vertex Pharmaceuticals as a Senior GL Accountant in 2006. Yewande then moved on to FORUM Pharmaceuticals (formerly Envivo Pharmaceuticals) as the Manager of Accounting, where they successfully implemented Oracle Cloud Fusion Financial ERP and R&D Logic. In 2016, they joined CRISPR Therapeutics, first as a Senior Manager, Accounting, and later as an Associate Director, Accounting. Yewande is currently serving as the Director Of Accounting at BlueRock Therapeutics. Throughout their career, Yewande has been responsible for various accounting functions, including month-end close processes, financial reporting, budgeting, and variance analysis.

From 2000 to 2002, Yewande Fashakin attended Bentley University, where they earned a Bachelor of Science degree in Accounting.